Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries

NCT ID: NCT07036393

Last Updated: 2025-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was done to:

* Determine the therapeutic efficacy of acupuncture as physical therapy approach in minimizing pain post upper abdominal surgeries.
* Determine the therapeutic efficacy of transcutaneous electrical nerve stimulation in minimizing pain post upper abdominal surgeries.
* Compare the efficacy and safety of Transcutaneous electrical nerve stimulation versus acupuncture in minimizing pain post upper abdominal surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative pain is caused by tissue damage from surgical incisions, triggering acute nociceptive activity in sensory nerve endings. Pain sensations reach the brain through dorsal horn, where it is recognized and interpreted. Management modalities include pharmacologic and non-pharmacologic methods. This study aims to provide a guideline on the effect of acupuncture and transcutaneous electrical nerve stimulation on pain reduction after upper abdominal surgeries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acupuncture Transcutaneous Electrical Nerve Stimulation Pain Upper Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupuncture

This group includes 20 patients who will receive Acupuncture 4 weeks (3times/week) and medical treatment

Group Type EXPERIMENTAL

Acupuncture

Intervention Type OTHER

Cholecystectomy involves a procedure where patients' spines are kept in position and skin around the acupoints is disinfected with 75% alcohol. Acupuncture treatment is given when patients return to units within 2 hours after surgery. The needles are inserted using disposable sterile needles and manipulated to induce a sense of "De qi" (soreness, numbness, distension, or heaviness). Gastrectomy involves daily acupuncture sessions for 5 consecutive days, starting on postoperative day 1. The needles are inserted perpendicular to the acupoints in the extremities to a depth of approximately 20 mm from the skin surface.

drugs

Intervention Type OTHER

analgesics and nonsteroidal anti-inflammatory drugs

Transcutaneous electrical nerve stimulation

This group includes 20 patients who will receive Transcutaneous electrical nerve stimulation 4 weeks (3times/week) and medical treatment

Group Type ACTIVE_COMPARATOR

Transcutaneous electrical nerve stimulation

Intervention Type OTHER

Patients will receive a transcutaneous electrical nerve stimulation unit (ENNRAF) for up to 48 hours post-surgery, with instructions to self-titrate intensity for pain relief. Postoperative stimulation will be 20-40 milliampere and pulse width 5

drugs

Intervention Type OTHER

analgesics and nonsteroidal anti-inflammatory drugs

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupuncture

Cholecystectomy involves a procedure where patients' spines are kept in position and skin around the acupoints is disinfected with 75% alcohol. Acupuncture treatment is given when patients return to units within 2 hours after surgery. The needles are inserted using disposable sterile needles and manipulated to induce a sense of "De qi" (soreness, numbness, distension, or heaviness). Gastrectomy involves daily acupuncture sessions for 5 consecutive days, starting on postoperative day 1. The needles are inserted perpendicular to the acupoints in the extremities to a depth of approximately 20 mm from the skin surface.

Intervention Type OTHER

Transcutaneous electrical nerve stimulation

Patients will receive a transcutaneous electrical nerve stimulation unit (ENNRAF) for up to 48 hours post-surgery, with instructions to self-titrate intensity for pain relief. Postoperative stimulation will be 20-40 milliampere and pulse width 5

Intervention Type OTHER

drugs

analgesics and nonsteroidal anti-inflammatory drugs

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who will have pain after upper abdominal surgery.
* Adult patients will be between 20 and 45 years of age.
* Both sexes will be included.
* Patients have no contraindications for acupuncture or transcutaneous electrical nerve stimulation.
* Patients with good compliance and fit for treatment.
* This study will be applied on upper abdominal surgeries \[laparoscopic cholecystectomy, Gastrectomy\].
* Physical therapy will be used for up to 48 hours after surgery or until the time of discharge.

Exclusion Criteria

* Patients with other causes of pain other than that after upper abdominal surgery.
* Patients who will have any contraindication for both therapies used.
* Patients with cardiovascular disease, liver, or renal disease.
* Patients with malignant tumors.
* Patients with metal or electronic implants.
* Patients with autoimmune disease.
* Pregnancy, postpartum period, breastfeeding.
* Patients with recent injury in the treatment area
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samar Saad Nazim Mohamed

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mansoura international hospital

Al Mansurah, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Samar Saad Nazim Mohamed, physical therapist

Role: CONTACT

01003097314

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Samar Saad Nazim Mohamed, physical therapist

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Samar-005748

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.